ClinVar Miner

Variants studied for platelet-type bleeding disorder 17

Included ClinVar conditions (1):
Minimum submission review status: Collection method:
Minimum conflict level:
Gene type:
ClinVar version:

If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.

pathogenic likely pathogenic uncertain significance likely benign benign total
7 3 12 1 0 22

Gene and significance breakdown #

Total genes and gene combinations: 1
Download table as spreadsheet
Gene or gene combination pathogenic likely pathogenic uncertain significance likely benign total
GFI1B 7 3 12 1 22

Submitter and significance breakdown #

Total submitters: 12
Download table as spreadsheet
Submitter pathogenic likely pathogenic uncertain significance likely benign total
ISTH-SSC Genomics in Thrombosis and Hemostasis, KU Leuven, Center for Molecular and Vascular Biology 3 3 5 1 12
OMIM 4 0 0 0 4
Genetics and Molecular Pathology, SA Pathology 0 1 2 0 3
Revvity Omics, Revvity 0 0 2 0 2
Baylor Genetics 0 0 1 0 1
Fulgent Genetics, Fulgent Genetics 0 0 1 0 1
Institute for Human Genetics and Genomic Medicine, Uniklinik RWTH Aachen 0 0 1 0 1
Division of Human Genetics, Children's Hospital of Philadelphia 0 0 1 0 1
Johns Hopkins Genomics, Johns Hopkins University 0 0 1 0 1
Zotz-Klimas Genetics Lab, MVZ Zotz Klimas 0 0 1 0 1
Lifecell International Pvt. Ltd 0 1 0 0 1
Neuberg Centre For Genomic Medicine, NCGM 1 0 0 0 1

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.